Corporate and Institutional Partners
The business and institutional communities are integral partners in stemming the spread of viral diseases worldwide. Viral outbreaks, such as SARS-CoV-2 / COVID19, know no boundaries and spread rapidly beyond national borders. They are accompanied by uncertainty, social instability, and can cause significant losses to workforces, productivity, and revenue streams. Multinational corporations, businesses, and institutions with international interests are vital partners in preparations against current and future potential pandemics and in stopping the spread of viruses.
The main goal of corporate and institutional partnerships is to link the these organizations with leading medical virologists. In doing so, these partnerships support cutting edge viral research, drug and vaccine development, training activities, as well as aid in increased awareness of medical virology issues and strengthening international viral preparedness and response.
The Global Health Security Agenda (GHSA) was launched in February 2014 and is a growing partnership of over 50 nations, international organizations, and non-governmental stakeholders to help build countries’ capacity to help create a world safe and secure from infectious disease threats and elevate global health security as a national and global priority.
The Coalition for Epidemic Preparedness Innovations (CEPI) is a new alliance between governments, industry, academia, philanthropy, intergovernmental institutions, such as the WHO, and civil society. We exist to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics.